Price
Financials
Standalone, Rs crore| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 11.53 | 8.59 | 6.52 | 1.59 | 0.12 | 0.22 | 0.00 |
| Operating costs | 15.35 | 8.46 | 12.82 | 3.52 | 0.67 | 2.53 | 0.18 |
| EBITDA | -3.82 | 0.13 | -6.30 | -1.93 | -0.55 | -2.31 | -0.18 |
| EBITDA margin % | -33.13% | 1.51% | -96.63% | -121.38% | -458.33% | -1,050.00% | |
| Depreciation & amortisation | 0.78 | 0.78 | 0.65 | 0.42 | 0.41 | 0.06 | 0.06 |
| Finance costs | 1.35 | 1.56 | 3.14 | 0.28 | 0.27 | 4.55 | 0.00 |
| Non-operating income | 1.93 | -1.93 | 1.29 | 0.49 | 0.16 | -7.10 | 0.01 |
| Pre-tax profit | -4.02 | -4.14 | -8.80 | -2.14 | -1.07 | -14.02 | -0.23 |
| Effective tax rate % | -40.55% | 28.74% | 0.11% | 0.00% | 0.00% | 0.00% | 0.00% |
| Profit after tax | -2.39 | -5.33 | -8.81 | -2.14 | -1.07 | -14.02 | -0.23 |
| Earnings per share (Rs) | -2.78 | -6.21 | -10.26 | -2.49 | -1.25 | -16.33 | -0.27 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | % | % | % | -100% | ||
| Profit CAGR | % | 14% | 24% | 95% | ||
| Share price CAGR | % | % | % | % | ||
| Average return on equity | % | % | % | % |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 15.94 | 16.27 | 15.62 | 15.19 | 14.78 | 1.40 | 1.34 |
| Capital work in progress | 1.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 0.40 |
| Investments | 0.13 | 0.12 | 0.14 | 0.40 | 0.12 | 0.12 | 0.12 |
| Current & other assets | 19.70 | 13.14 | 6.66 | 3.69 | 6.74 | 3.42 | 3.42 |
| Total assets | 36.87 | 29.53 | 22.42 | 19.28 | 21.64 | 5.34 | 5.28 |
| Share capital | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 |
| Reserves & surplus | 3.29 | -2.04 | -10.85 | -12.99 | -14.06 | -27.38 | -27.61 |
| Total debt | 20.99 | 19.89 | 22.50 | 21.91 | 22.14 | 22.34 | 22.63 |
| Other liabilities & provisions | 4.02 | 3.11 | 2.20 | 1.79 | 4.99 | 1.81 | 1.69 |
| Equity + liabilities | 36.87 | 29.53 | 22.42 | 19.28 | 21.64 | 5.34 | 5.28 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -6.41 | -0.92 | -3.16 | 1.02 | -0.28 | 1.76 | -0.94 |
| Investing cash flow | -1.02 | 0.16 | 0.01 | -0.27 | 0.29 | -2.65 | 0.01 |
| Free cash flow (after capex) | -7.58 | -0.92 | -3.16 | 1.02 | -0.28 | -0.91 | -0.94 |
| Financing cash flow | 7.40 | -1.10 | 2.62 | -0.87 | 0.00 | 1.60 | 0.29 |
| Net change in cash | -0.03 | -1.86 | -0.53 | -0.12 | 0.01 | 0.71 | -0.64 |
| Cash conversion (OCF / EBITDA) % | 168% | -692% | 50% | -53% | 44% | -76% | 522% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Return on capital employed % | 5.94% | -24.27% | -9.76% | -4.69% | -3.47% | -6.46% | |
| Receivable days | 59.83 | 92.21 | 105.25 | 9.18 | 517.08 | 33.18 | |
| Inventory days | 378.12 | 535.06 | 89.37 | 323.48 | 2,737.50 | 244.55 | |
| Payable days | 125.92 | 181.81 | 43.07 | 171.26 | 1,642.50 | 481.80 | |
| Cash cycle (days) | 312.03 | 445.45 | 151.54 | 161.41 | 1,612.08 | -204.07 | |
| Working capital days | 350.75 | 367.55 | 210.49 | 316.79 | 3,954.17 | 132.73 |
Fundamentals
Market value₹ Cr.
Last price₹ 1.71
Book value / share₹ -22.2
Return on capital-6.46 %
Return on equity%
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-100%
Profit CAGR (TTM)95%
Standalone figures.
Valuation
P/B, 3-year average-0.44x
Profitability
Operating margin (excl. other income)-121.38%
Operating margin (incl. other income)-90.57%
EBITDA margin-90.57%
Pre-tax margin-134.59%
Net profit margin-134.59%
ROE63.88%
ROCE-9.86%
ROA-10.26%
ROE, 3-year average-136.22%
ROCE, 3-year average-14.28%
ROA, 3-year average-20.08%
ROIC (approx.)-10.68%
Other income / net worth-11.09%
Growth
Sales growth (latest year)-75.61%
Sales CAGR, 3 years-48.34%
Per share
EPS (TTM)Rs -2.49
EPS (latest year)Rs -2.49
EPS, 3-year averageRs -6.32
Book value per shareRs -5.15
Sales per shareRs 1.85
Cash flow per shareRs 1.19
Efficiency
Asset turnover0.08x
Fixed asset turnover0.10x
Inventory turnover1.36x
Inventory days268 days
Debtor days9 days
Debtors turnover39.75x
Leverage
Total debtRs 22 Cr
Cash and bankRs 0 Cr
Net debtRs 22 Cr
Debt to equity-4.96x
Interest coverage-6.64x
Owners' fund to total sources-22.93%
Debt to assets113.64%
Cash flow
Operating cash flow (latest year)Rs 1 Cr
Investing cash flow (latest year)Rs -0 Cr
Financing cash flow (latest year)Rs -1 Cr
Net change in cash (latest year)Rs -0 Cr
Sales to cash flow1.56x
Statement figures
Net sales (TTM)Rs 2 Cr
Net sales (latest year)Rs 2 Cr
Operating profit excl. other income (latest year)Rs -2 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -2 Cr
Profit before tax (TTM)Rs -2 Cr
Net profit (TTM)Rs -2 Cr
Net profit (latest year)Rs -2 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 4 Cr
Total income (latest year)Rs 2 Cr
Share capitalRs 9 Cr
ReservesRs -13 Cr
Shareholders' fundsRs -4 Cr
Total assetsRs 19 Cr
Net blockRs 15 Cr
InvestmentsRs 0 Cr
ReceivablesRs 0 Cr
InventoryRs 2 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)0.86
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 4 of 8| serious | Negative equity Shareholders' equity is negative |
| look | Inventory outrunning sales Inventory grew -25% vs sales -76% in 2012 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of EPIC Enzymes Pharma & Industrial Chemicals Ltd?
EPIC Enzymes Pharma & Industrial Chemicals Ltd (524374) has a market capitalisation of Rs Cr. at the close.